If you've been practicing for more than 15 years, there's a good chance a DSO has already called. Maybe more than once. They're persistent — and the offers can sound genuinely attractive. A check with a lot of zeros, a path to liquidity, and the promise that "nothing really changes."
I've talked to a lot of dentists about this decision. The ones who made it well — whether they took the DSO deal or didn't — had something in common: they understood what they were actually comparing. Not just the headline numbers, but the full picture of each path.
Here's that comparison, without the sales pitch on either side.
The Three Paths — A Quick Reset
When dentists ask "should I sell to a DSO," they're usually comparing three real options, not two:
1. DSO sale (full or partial) — Sell all or part of your equity to a Dental Service Organization. DSOs bring capital, systems, and often a faster close. Full sale means you're out (usually with a 1–3 year transition). Partial sale means you roll equity and keep practicing while participating in a "second bite" if the DSO is acquired at a higher multiple.
2. Private sale (independent buyer) — Sell to an individual dentist: an associate, a competitor, or an outside buyer sourced through a broker or your network. More flexible structure, preserves more culture, but financing is harder for buyers and deals move slower.
3. Partnership / associate buy-in — Bring in an associate who buys in over time, often at a discount to market value in exchange for the ownership path. Ideal if you have a strong associate in place and want a longer, staged runway out of the practice.
The right path depends on your timeline, financial situation, and what post-exit life looks like for you. I put together a detailed side-by-side breakdown of all three — across eight factors including control, speed, and tax treatment — in the DSO Comparison Guide. That's the reference doc if you want the full matrix.
This article is different. It's about the things that don't fit neatly in a comparison table — the hidden mechanics, the real risks, and how to think about a DSO offer when you're actually staring at one.
What the DSO Offer Actually Looks Like
The headline number in a DSO offer is almost never what you actually receive. Understanding the structure is the first thing you need to do before evaluating any offer.
Upfront cash at close is the most visible piece — and typically the smallest portion of your theoretical total deal value. DSOs often pay 60–80% of the purchase price at close, with the rest tied to future performance or equity events.
Equity rollover is where the DSO pitch gets interesting. Instead of cash, you receive equity in the DSO (or in a regional platform) representing a portion of your deal value. The idea: if the DSO is acquired or goes public at a higher multiple in the future, your rollover equity is worth more than cash would have been. This is the "second bite" story, and it can be real. The risk: the rollover equity is illiquid, has no guaranteed value, and is subject to the DSO's future performance and capital structure. Some dentists have had rollover equity pay out 2–3x their initial expectation. Others have received close to nothing when the DSO struggled post-acquisition.
Earnouts tie a portion of your deal value to future performance metrics — usually EBITDA targets in years 1–3 post-close. If the practice hits the numbers, you collect the earnout. If it doesn't — because patient volume dips, a key associate leaves, or the integration costs more than projected — you may not. Earnouts on paper look like part of the total deal value. In practice, they're conditional cash. Read the targets carefully before assuming you'll hit them.
Holdbacks are a different category: money withheld from your close payment to cover indemnification claims, representations-and-warranties breaches, or other deal mechanics. Holdbacks typically release 12–24 months post-close, assuming no claims. They're standard, but the amount and conditions matter. A 10% holdback on a $3M deal is $300K sitting in escrow for two years — factor that into your cash flow expectations.
Put it together: a "$4 million DSO offer" might actually be $2.4M at close, $800K in earnouts with meaningful conditions, $600K in illiquid rollover equity, and $200K in holdbacks releasing over two years. The headline is real. The structure is what you're actually signing.
What DSOs Don't Advertise
DSOs are sophisticated acquirers. Their offers are designed to look competitive. Here's what gets buried in the details.
Real estate isn't always included — and if you own your building, this is a major factor. Some DSOs acquire real estate; others require you to sell-leaseback or sign a long-term lease. A 15-year lease at below-market rent can significantly erode your total exit value.
Non-competes are serious. The radius and duration of non-compete provisions in DSO deals have expanded. A 10-mile, 5-year non-compete in a suburban market can effectively end your ability to practice in your own community. If you're not done practicing, negotiate this hard.
Post-sale autonomy varies more than reps say. Some DSOs genuinely leave clinical decision-making to the dentist. Others standardize everything — purchasing, scheduling templates, referral policies, lab relationships. Your associates, your front desk, your culture may look very different 18 months post-close. Talk to dentists who've sold to the same DSO, not the ones the DSO refers you to.
The multiple math matters. DSOs typically pay 4–6x EBITDA for individual practices, sometimes more for large or specialty practices. But what's in the EBITDA calculation? Adjustments for owner compensation, add-backs for one-time expenses, and how they handle hygiene production vs. dentist production all affect the denominator. Two practices at the same stated EBITDA can have very different actual deal values depending on how the calculation is run.
None of this means DSO deals are bad. It means they require dental-specific expertise. Someone who has coordinated 20+ dental transactions is not optional at this level — the cost of getting it wrong is a rounding error compared to what's at stake. This is the kind of complexity the Virtual Family Office was built to navigate. Book a Second Opinion Call before you sign anything.
When the Independent Sale Makes More Sense
The private sale path is slower and more complex — but it's not the consolation prize dentists sometimes treat it as.
Individual buyers (associates, competitors, outside dentists) typically pay 3–5x EBITDA for private practices, which looks lower than DSO multiples. But the comparison isn't as clean as it appears. Private sales are usually all-cash or SBA-financed, which means what you see is largely what you get. No earnouts, no rollover equity, no holdbacks. The net effective price, factoring out the conditional components of a DSO offer, is often closer than the headlines suggest.
Private sales also give you more flexibility on deal structure, transition timeline, and — critically — non-compete terms. If you're planning to continue practicing part-time, or if you want to transition over five years rather than two, an individual buyer is far more likely to accommodate that than a DSO with standardized acquisition processes.
Culture preservation matters here too. For dentists who care deeply about what happens to their team, their patients, and the character of their practice, a carefully chosen individual buyer — especially a trained associate — is often the best vehicle for that.
The tradeoff is real: finding the right buyer takes longer, SBA financing can fall apart, and the deal process is less professional on the buyer side. This is where local market knowledge and coordinated deal experience matter most.
The Complete Guide to Dental Practice Exit Planning covers the full spectrum of exit path considerations — including how your timeline affects which path is actually available to you.
The Moment DSO Pressure Becomes a Problem
Here's the scenario I see most often go sideways: a dentist gets a DSO offer at a moment of vulnerability — burned out, dealing with a personal situation, hit by a difficult year financially. The offer feels like a lifeline. The DSO reps are persistent, attentive, and good at creating urgency. The dentist signs a letter of intent before getting an independent perspective, or before fully understanding what they're comparing it to.
A signed LOI isn't a sale — but it creates significant momentum and often exclusivity. Once you're in exclusivity with a DSO, your leverage drops. The price rarely goes up from LOI to close. Terms sometimes get worse. And backing out has real costs, reputational and sometimes financial.
The single most useful thing you can do when a DSO offer arrives: slow down. You are not required to respond on their timeline. A serious offer doesn't expire in 72 hours. Any DSO that creates that kind of artificial urgency is using pressure as a negotiation tactic — which is a signal worth noting.
Before you sign anything, you want to know your alternatives. What would a private sale actually yield? What would a buy-in with your strongest associate look like? What's your practice worth to the market vs. to this one buyer? Without that baseline, you can't evaluate the offer — you can only react to it.
How to Know Which Path Is Right for You
The honest answer is that it depends on things that are specific to your practice and your life — and the right move for a 58-year-old with a high-EBITDA specialty practice in a suburban market is different from the right move for a 47-year-old general dentist in a smaller market who wants to keep practicing for another decade.
What I've found is that the dentists who make this decision well start with an honest self-assessment before they evaluate any deal. They know their numbers, they know their timeline, and they know what they actually want post-exit — financially and personally.
The Practice Exit Readiness Scorecard is the fastest way to build that baseline. It's 10 questions, evaluates your exit readiness across five dimensions, and gives you a personalized score with specific insights for where you stand right now. If a DSO has already called, or if you're thinking about timing your exit in the next three years, it's the right starting point.
When you know where you stand, you stop reacting to offers and start evaluating them. That's the difference between dentists who leave money on the table and dentists who don't.